AlzeCure will attend the JP Morgan meeting in San Francisco, which takes place every year in January. It is the world’s leading lifescience partnering & investor meeting. We at AlzeCure are looking forward to present our company & ongoing projects in Alzheimer’s & pain, meeting with pharmaceuticals companies, partners & investors.
Hope to see you there.
Reach out if you would like to meet up: info@alzecurepharma.com
AlzeCure will host two breakfast seminars during the JP Morgan meeting.
January 13 2026 at 8.00-8.45 am. Alzheimer’s Disease and our innovative therapeutic candidates ACD856 and ACD680.
January 14 2026 at 8.00-8.45 am. Neuropathic Pain research, the orphan disorder Erythromelalgia, and our innovative clinical phase 2 therapeutic candidate, ACD440.
Location: Business Sweden’s office at 100 Montgomery Street, floor 16, 94104 San Francisco
If you like to attend reach out to dimitrina.dimitrova@alzecurepharma.com before EOB 8 Jan.